According to Reuters, Trump directed Office of Management and Budget Director Russell Vought to prepare an executive order creating a board that would review NIH grants. The proposal has not yet been issued as an executive order, and important details could still change.
Background
NIH distributes federal money to universities, hospitals and other research institutions for biomedical and public-health research. Congress appropriates that money and also places conditions on how it can be spent. The 2026 NIH funding rules, for example, identify statutory restrictions that apply to research awards.
The proposed system reportedly would add another level of review. Reuters reported that the board would include Vought and NIH Director Jay Bhattacharya and that both would have to agree before funding could move forward.
The proposal comes during a broader dispute over how much control presidential administrations should exercise over federal research spending. The Trump administration has sought to stop funding for research it considers inconsistent with administration policy, including some work involving diversity, gender identity and climate change.
That dispute is already in court. On September 16, a group of scientists filed a lawsuit alleging that NIH has been using politically sensitive keywords when reviewing grants. The plaintiffs argue that the process discriminates against particular viewpoints. The administration has defended changes to grant policy as an effort to ensure that taxpayer-supported research reflects lawful federal priorities and rigorous scientific standards. The lawsuit remains unresolved.
What Different Sides Are Saying
Supporters of stronger White House oversight argue that scientific peer review should not make federal research agencies effectively independent of elected officials. Congress provides the money, but executive agencies administer it. From this perspective, political leaders have a legitimate role in setting priorities and preventing federal grants from supporting programs that conflict with administration policy.
Fact-check: Presidential administrations already influence research priorities through budgets, agency leadership, regulations and executive policy. The reported proposal would go further by potentially giving White House budget officials direct approval authority over individual NIH grants.
Critics argue that such a system could politicize scientific decisions that traditionally rely heavily on expert peer review. They say researchers could begin shaping proposals around the political preferences of the administration in power rather than primarily around scientific merit.
A September 18 Washington Post report described disagreement inside the administration itself, with Vought pushing for additional scrutiny of grants and Bhattacharya resisting some proposed interventions.
Fact-check: The existence of disagreement over particular grants does not establish that NIH’s existing peer-review system is politically neutral or that a White House review board would necessarily reject scientifically strong research. The central dispute concerns who should have final authority and what criteria should guide that authority.
Note on Scope
The reported executive order had not been publicly released as of September 20, so its exact language, legal basis and scope remain unknown. Reuters reported that the White House and relevant agencies had not commented publicly on the proposal. This article therefore describes a proposal under consideration, not a policy that has already taken effect.
Related Links
- Reuters: Trump and NIH grant oversight
- Washington Post: NIH funding dispute
- Scientists challenge NIH screening
- NIH: 2026 legislative funding mandates
- NIH high-risk research policy
Discussion Questions
- How much control should presidents have over federal research funding?
- What are the advantages of using scientists to review research proposals?
- What are the disadvantages of giving experts substantial control over public money?
- Should elected officials be able to reject research grants because they conflict with administration priorities?
- How could political review affect the kinds of research scientists choose to pursue?
- Can scientific funding ever be completely separated from politics?
- What safeguards could prevent both political bias and unaccountable grant-making?
- Should Congress establish clearer rules governing political involvement in federal research grants?
- Would greater government oversight increase or decrease public confidence in NIH?
- How should policymakers balance scientific independence with democratic accountability?
